SK

Sandip Krshunath Deshmukh

Active Director Designated Partner DIN 07360853
DIN 07360853 First appointment Mar 2016 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Sandip Krshunath Deshmukh

Data last updated:

Sandip Krshunath Deshmukh is a Designated Partner at Shree Chatrapati Imsr Diagnostic Llp (since 2016). The company operates in Healthcare.

DIN 07360853
Primary Designation Designated Partner
Industry Healthcare
First Appointment 18 Mar 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner18 Mar 20162016Active

Board colleagues of Sandip Krshunath Deshmukh

Directorship timeline

Open interactive timeline →
Shree Chatrapati Imsr Diagnostic Llp
Premium access

Shareholding and investment profile for Sandip Krshunath Deshmukh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sandip Krshunath Deshmukh

Sandip Krshunath Deshmukh currently holds 1 directorship: Shree Chatrapati Imsr Diagnostic Llp (Designated Partner, since 18 Mar 2016).

Sandip Krshunath Deshmukh was first appointed on 18 Mar 2016 as Designated Partner at Shree Chatrapati Imsr Diagnostic Llp.

The current boards of Sandip Krshunath Deshmukh's companies include Mahadev Ramchandra Deshmukh (Shree Chatrapati Imsr Diagnostic Llp), Raviteja Pandurang Mane (Shree Chatrapati Imsr Diagnostic Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available